Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of prazosin to prevent
cytokine storm syndrome and severe complications in hospitalized patients with Coronavirus
disease 2019 (COVID-19).